Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Medi-Weightloss vs RxSpan MD

Medi-Weightloss
Graded #118

Lower grade

vs+17.200000000000003
RxSpan MD
Graded #4

Higher grade

The verdict

RxSpan MD takes it — 86.8/100 to 69.6/100.

RxSpan MD grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. A physician-led telehealth under board-certified founder Dr. John Diaz with a broad GLP-1 menu — compounded semaglutide and tirzepatide by injection or oral capsule, plus a brand-name lane and microdosing — on transparent all-inclusive pricing to all 50 states.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueRxSpan MD +32
54
86
Dose & formulationRxSpan MD +24
65
89
Clinical oversightRxSpan MD +1
87
88
Labs & monitoringMedi-Weightloss +7
90
83
FulfillmentRxSpan MD +24
65
89
Contract termsRxSpan MD +30
55
85
Medi-Weightloss · left barRxSpan MD · right bar

The numbers

MetricMedi-WeightlossRxSpan MD
WeighScore69.6/10086.8/100
GradeCB
Scorecard rank#118#4
Semaglutide$199/mo (promotional rate, brand-name)From $194/mo
TirzepatideNot disclosed$329/mo
CoverageCoverage not publishedAll 50 states
Brand-name accessYesYes
Oral / sublingualInjection onlyYes
Medi-Weightloss

Graded #118 · C

Strengths

  • Both branded (Wegovy, Zepbound) and compounded semaglutide/tirzepatide
  • Established brand with 130+ physician-supervised locations nationwide
  • Telehealth plus in-person clinic options
  • Accepts insurance at many locations; HSA/FSA welcome
  • Includes body-composition analysis and personalized plans

Where it loses points

  • Ongoing medication pricing not transparently posted; varies by plan
  • $199 new-patient visit fee before medication costs
  • Frequent (often weekly) visits expected for some patients
  • Compounded products are not FDA-approved or evaluated
RxSpan MD

Graded #4 · B

Strengths

  • Available in all 50 states
  • Transparent, all-inclusive published pricing — consult, medication, supplies, shipping and support, cancel anytime, from ~$194/mo compounded semaglutide on an annual plan
  • Both injectable and a real oral (capsule) route, plus compounded and an advertised brand-name lane
  • Physician-led by a named, board-certified founder (Dr. John Diaz) with 24/7 messaging and coaching

Where it loses points

  • Compounded semaglutide/tirzepatide are not FDA-approved (not the same as Wegovy/Ozempic/Zepbound)
  • Published pricing is for the compounded line — brand-name pricing isn’t itemized
  • A prescription isn’t guaranteed — a provider reviews eligibility after checkout

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard